Local infiltration of neuropeptide y as a potential therapeutic agent against apoptosis and fibrosis in a swine model of hypercholesterolemia and chronic myocardial ischemia

European Journal of Pharmacology

Volumn 718, Issue 1-3, 2013, Pages 261-270

  Matyal, Robina ^a,b   Sakamuri, Sruthi ^a   Wang, Angela ^a   Mahmood, Eitezaz ^a   Robich, Michael P ^a,b   Khabbaz, Kamal ^a,b   Hess, Philip E ^a,b   Sellke, Frank W ^b,c,d   Mahmood, Feroze ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Chronic ischemia; Fibrosis; Neuropeptide Y; Oxidative stress

Indexed keywords

ANGIOTENSIN I; GELATINASE B; GLUCOSE TRANSPORTER 4; MANGANESE SUPEROXIDE DISMUTASE; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW; CELL SURVIVAL; CHOLESTEROL DIET; CONTROLLED STUDY; DIASTOLE; DRUG ADMINISTRATION; FATTY ACID METABOLISM; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PERFUSION; HYPERCHOLESTEROLEMIA; IMMUNOBLOTTING; MALE; NERVE GROWTH; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WINE;

CHRONIC ISCHEMIA; FIBROSIS; NEUROPEPTIDE Y; OXIDATIVE STRESS;

ANIMALS; APOPTOSIS; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; DISEASE MODELS, ANIMAL; FATTY ACIDS; FIBROSIS; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HEART VENTRICLES; HYPERCHOLESTEROLEMIA; HYPERTROPHY; MALE; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PATHOLOGIC; NEUROPEPTIDE Y; OXIDATIVE STRESS; SWINE;

EID: 84887108265     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.08.023     Document Type: Article

References (31)

1. S. Ali, O. Shakil, T.H. Chen, H.J. Warraich, and R. Matyal An incidental finding during emergent vascular surgery: how far to go? Journal of Cardiothoracic and Vascular Anesthesia 26 2012 354 355
2. S. Baptista, A.R. Bento, J. Goncalves, L. Bernardino, T. Summavielle, A. Lobo, C. Fontes-Ribeiro, J.O. Malva, F. Agasse, and A.P. Silva Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures Neuropharmacology 62 2012 2413 2423
3. S. Boudina, and E.D. Abel Diabetic cardiomyopathy, causes and effects Reviews in Endocrine and Metabolic Disorders 11 2010 31 39
4. M. Calvani, E. Reda, and E. Arrigoni-Martelli Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions Basic Research in Cardiology 95 2000 75 83
5. J.X. Chen, and A. Stinnett Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice Diabetes 57 2008 3335 3343
6. M. Chottova Dvorakova, S. Wiegand, M. Pesta, J. Slavikova, V. Grau, J. Reischig, J. Kuncova, and W. Kummer Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes Neuroscience 151 2008 1016 1028
7. J. Goncalves, C.F. Ribeiro, J.O. Malva, and A.P. Silva Protective role of neuropeptide Y Y(2) receptors in cell death and microglial response following methamphetamine injury European Journal of Neuroscience 36 2012 3173 3183
8. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., and C. Lenfant Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
9. R. Hellweg, and H.D. Hartung Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy Journal of Neuroscience Research 26 1990 258 267
10. D. Hirsch, and Z. Zukowska NPY and stress 30 years later: the peripheral view Cellular and Molecular Neurobiology 32 2012 645 659
11. M. Ieda, H. Kanazawa, Y. Ieda, K. Kimura, K. Matsumura, Y. Tomita, T. Yagi, T. Onizuka, K. Shimoji, S. Ogawa, S. Makino, M. Sano, and K. Fukuda Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts Circulation 114 2006 2351 2363
12. S. Ivanovic-Matic, M. Mihailovic, S. Dinic, V. Martinovic, D. Bogojevic, I. Grigorov, and G. Poznanovic The absence of cardiomyopathy is accompanied by increased activities of CAT, MnSOD and GST in long-term diabetes in rats Journal of Physiological Sciences 60 2010 259 266
13. D. Jacques, S. Sader, C. Perreault, and D. Abdel-Samad NPY and NPY receptors: presence, distribution and roles in the regulation of the endocardial endothelium and cardiac function EXS 2006 77 87
14. D. Jacques, S. Sader, C. Perreault, D. Abdel-Samad, and C. Provost Roles of nuclear NPY and NPY receptors in the regulation of the endocardial endothelium and heart function Canadian Journal of Physiology and Pharmacology 84 2006 695 705
15. D. Jacques, S. Sader, C. Perreault, A. Fournier, G. Pelletier, A.G. Beck-Sickinger, and M. Descorbeth Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium Canadian Journal of Physiology and Pharmacology 81 2003 288 300
16. R. Khurana, and M. Simons Endothelial progenitor cells: precursors for angiogenesis Seminars in Thoracic and Cardiovascular Surgery 15 2003 250 258
17. J.A. Kim, Y. Wei, and J.R. Sowers Role of mitochondrial dysfunction in insulin resistance Circulation Research 102 2008 401 414
18. A.D. Lassaletta, L.M. Chu, and F.W. Sellke Therapeutic neovascularization for coronary disease: current state and future prospects Basic Research in Cardiology 106 2011 897 909
19. D.M. Levy, S.S. Karanth, D.R. Springall, and J.M. Polak Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study Diabetologia 32 1989 427 433
20. J.M. Lundberg, L. Terenius, T. Hokfelt, C.R. Martling, K. Tatemoto, V. Mutt, J. Polak, S. Bloom, and M. Goldstein Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function Acta Physiologica Scandinavica 116 1982 477 480
21. R. Matyal, L. Chu, F. Mahmood, M.P. Robich, A. Wang, P.E. Hess, S. Shahul, D.S. Pinto, K. Khabbaz, and F.W. Sellke Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia Journal of Molecular and Cellular Cardiology 53 2012 891 898
22. R. Matyal, F. Mahmood, M. Robich, H. Glazer, K. Khabbaz, P. Hess, C. Bianchi, R. Hagberg, S.X. Hu, and F.W. Sellke Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue European Journal of Pharmacology 665 2011 19 28
23. J.F. Morrison, S. Dhanasekaran, and F.C. Howarth Neuropeptide Y and CGRP concentrations in the rat tail artery: effects of age and two types of diabetes Peptides 30 2009 710 714
24. A.D. Nozdrachev, and P.M. Masliukov Neuropeptide Y and autonomic nervous system Zhurnal EvoliutsionnoÄ Biokhimii i Fiziologii 47 2011 105 112
25. A.V. Ovechkin, N. Tyagi, W.E. Rodriguez, M.R. Hayden, K.S. Moshal, and S.C. Tyagi Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice Journal of Applied Physiology 99 2005 2398 2405
26. M.P. Robich, R. Matyal, L.M. Chu, J. Feng, S.H. Xu, R.J. Laham, P.E. Hess, C. Bianchi, and F.W. Sellke Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia Journal of Molecular and Cellular Cardiology 49 2010 1022 1030
27. C. Sanchez-Lasheras, A.C. Konner, and J.C. Bruning Integrative neurobiology of energy homeostasis-neurocircuits, signals and mediators Frontiers in Neuroendocrinology 31 2010 4 15
28. C.G. Tocchetti, V. Caceres, B.A. Stanley, C. Xie, S. Shi, W.H. Watson, B. O'Rourke, R.C. Spadari-Bratfisch, S. Cortassa, F.G. Akar, N. Paolocci, and M.A. Aon GSH or palmitate preserves mitochondrial energetic/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes/hearts from type 2 diabetic mice Diabetes 61 2012 3094 3105
29. Y. Wang, D. Zhang, M. Ashraf, T. Zhao, W. Huang, A. Ashraf, and A. Balasubramaniam Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction American Journal of Physiology: Heart and Circulatory Physiology 298 2010 H275 H286
30. ±cells and reduces myocardial apoptosis in db/db mouse infarcted hearts PLOS ONE 7 2012 e35905
31. Z. Zukowska-Grojec, E. Karwatowska-Prokopczuk, W. Rose, J. Rone, S. Movafagh, H. Ji, Y. Yeh, W.T. Chen, H.K. Kleinman, E. Grouzmann, and D.S. Grant Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium Circulation Research 83 2 1998 187 195